Description
ERLOTERO 150mg Tablet 30’s erlotinib 150mg tablets, 30-count: a potent anticancer agent, erlotinib is indicated for the treatment of locally advanced, metastatic, or recurrent non-small cell lung cancer (nsclc) after failure of at least one prior chemotherapy regimen. This oral medication inhibits the epidermal growth factor receptor (EGFR), thereby slowing or stopping the growth of cancer cells. Erlotinib is a crucial component in comprehensive cancer care, offering hope to patients battling advanced NSCLC. Always consult with a healthcare provider for proper usage and dosage instructions.
Reviews
There are no reviews yet.